| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/19/2009 | WO2009022746A1 Nitrogen-containing heterocyclic compound and pest control agent |
| 02/19/2009 | WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | WO2008157407A3 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 02/19/2009 | WO2008157404A3 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 02/19/2009 | WO2006065484A3 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 02/19/2009 | US20090048443 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048305 Antimicrobial ortho-Fluorophenyl Oxazolidinones For Treatment of Bacterial Infections |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048263 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents |
| 02/19/2009 | US20090048256 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048254 Salts and polymorphs of a vegf-r inhibitor |
| 02/19/2009 | US20090048251 4-(1h-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 02/19/2009 | US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048243 Therapeutic agent for attention-deficit hyperactivity disorder |
| 02/19/2009 | US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048223 Sulfonamide compound |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048213 Prodrug of cinnamide compound |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047249 Modulators of toll-like receptor 7 |
| 02/19/2009 | DE102007037373A1 New oxazolidinone derivatives are factor Xa inhibitors useful to treat e.g. acute coronary syndrome, myocardial infarction, angina pectoris, reocclusion, restenosis, stroke, artrial fibrillation, arrhythmia and blood clotting disorder |
| 02/19/2009 | CA2696488A1 Bicyclic sphingosine 1-phosphate analogs |
| 02/19/2009 | CA2696314A1 Therapeutic compounds |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |
| 02/19/2009 | CA2685605A1 Treatment of duchenne muscular dystrophy |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2024364A1 Heterocyclic compounds as calcium channel blockers |
| 02/18/2009 | EP2024358A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/18/2009 | EP2024357A2 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 02/18/2009 | EP2024355A2 Alkene piperidine derivatives as antiviral agents |
| 02/18/2009 | EP2024347A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 02/18/2009 | EP2024336A1 Novel pharmaceutical compositions |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP1723143B1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370806A Substituted 4-phenylpiperidines |
| 02/18/2009 | CN101370805A Novel pyridine derivatives |
| 02/18/2009 | CN101370799A Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors |
| 02/18/2009 | CN101370784A Polycyclic indazole derivatives that are erk inhibitors |
| 02/18/2009 | CN101370496A Novel thiophene derivatives as S1P1/EDG1 receptor agonists |
| 02/18/2009 | CN101367798A N-(2-pyrimidine oxygen based) benzyl hetercyclic compounds, preparation method and uses thereof |
| 02/17/2009 | US7491827 Aryl sulfonamides useful as inhibitors of chemokine receptor activity |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491821 2-(4-fluorophenyl)-4-propyl-oxazole-5-carboxylic acid {2-[4-(6-aminopyridin-2-yl)-piperazin-1-yl]-1-methyl-ethyl}amide; purinergic receptor antagonists, analgesics; urogenital, gastointestinal and respiratory system disorders |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491743 Inhibitors of cellular necrosis |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491735 e.g. N-(3-{4-[(4-Bromo-phenyl)-(3-chloro-benzyl)-amino]-piperidin-1-yl}-butyl)-3,5-dichloro-isonicotinamide; viricide, antiinflammation agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV) |
| 02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 02/17/2009 | US7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | US7491719 adrenergic blocking agents such as R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylamino]ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride, used for the treatment of repiratoty system disorders |
| 02/17/2009 | US7491717 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 02/17/2009 | US7491714 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 02/17/2009 | US7491713 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2009 | WO2009020616A1 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009019656A1 Pyridyl derivatives, their preparation and use |
| 02/12/2009 | WO2009019518A1 Pyrimidine compounds having a fgfr inhibitory effect |
| 02/12/2009 | WO2009019278A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/12/2009 | WO2009018925A1 Herbicide triazolylpyridine ketones |
| 02/12/2009 | WO2009018885A1 Dioxazinyl-substituted furyl-sulfonyl-aminocarbonyl compounds |
| 02/12/2009 | WO2009018807A1 Oxazolidinones as factor xa inhibitors, methods for the production thereof, and use thereof in therapy |
| 02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2008152073A3 Piperazine compounds with a herbicidal action |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090043104 reacting with alkyl halosulfonium compound, aryl halosulfonium compound, phosphoryl chloride, phosphorus pentachloride, thionyl chloride and triphenyl phosphine, in presence of alkali |
| 02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 02/12/2009 | US20090043091 Induce immunology response; anticancer agents; 6-(6-Morpholin-4-yl-4-oxo-4H-pyran-2-yl)-thianthrene-2-carboxylate sodium salt; 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-thianthrene-2-carboxylic acid methyl ester |
| 02/12/2009 | US20090042957 Substituted Oxyarenes |
| 02/12/2009 | US20090042954 Trans-2-(4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)-4-pyrrolidineacetic acid; have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity |
| 02/12/2009 | US20090042945 Benzo[d]isoxazol-3-yl-amine Compounds and Their Use as Vanilloid Receptor Ligands |
| 02/12/2009 | US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042918 Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3 |
| 02/12/2009 | US20090042897 Chemical Compounds |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042883 Antitumor agent |
| 02/12/2009 | US20090042882 Substituted acetamides as modulators of the ep2 receptor |
| 02/12/2009 | US20090042881 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |